Primecap Management CO Immuno Gen, Inc. Transaction History

Primecap Management CO

$134 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$3.75 - $20.05 $37,500 - $200,500	-10,000 Reduced 3.53%	273,100 $5.15 Million
Q1 2023 May 15, 2023	SELL	$3.67 - $4.92 $1.53 Million - $2.05 Million	-417,127 Reduced 59.57%	283,100 $1.09 Million
Q4 2022 Feb 13, 2023	SELL	$4.55 - $6.31 $127,855 - $177,311	-28,100 Reduced 3.86%	700,227 $3.47 Million
Q2 2022 Aug 11, 2022	SELL	$3.15 - $5.76 $89,775 - $164,160	-28,500 Reduced 3.77%	728,327 $3.28 Million
Q1 2022 May 11, 2022	SELL	$4.26 - $7.48 $20,874 - $36,652	-4,900 Reduced 0.64%	756,827 $3.6 Million
Q4 2021 Feb 11, 2022	SELL	$4.75 - $7.5 $129,200 - $204,000	-27,200 Reduced 3.45%	761,727 $5.65 Million
Q3 2021 Nov 12, 2021	SELL	$5.02 - $6.59 $74,798 - $98,191	-14,900 Reduced 1.85%	788,927 $4.47 Million
Q2 2021 Aug 10, 2021	SELL	$5.79 - $8.6 $244,917 - $363,780	-42,300 Reduced 5.0%	803,827 $5.3 Million
Q1 2021 May 14, 2021	SELL	$6.5 - $10.53 $355,550 - $575,991	-54,700 Reduced 6.07%	846,127 $6.85 Million
Q3 2020 Nov 13, 2020	SELL	$3.45 - $4.89 $145,935 - $206,847	-42,300 Reduced 4.49%	900,827 $3.24 Million
Q2 2020 Aug 13, 2020	SELL	$3.32 - $5.34 $182,600 - $293,700	-55,000 Reduced 5.51%	943,127 $4.34 Million
Q1 2020 May 14, 2020	SELL	$2.12 - $6.8 $5.67 Million - $18.2 Million	-2,676,800 Reduced 72.84%	998,127 $3.4 Million
Q4 2019 Feb 14, 2020	SELL	$2.25 - $5.8 $42,464 - $109,463	-18,873 Reduced 0.51%	3,674,927 $18.8 Million
Q3 2019 Nov 13, 2019	SELL	$2.22 - $3.39 $141,636 - $216,282	-63,800 Reduced 1.7%	3,693,800 $8.94 Million
Q1 2019 May 14, 2019	SELL	$2.41 - $5.91 $17,834 - $43,734	-7,400 Reduced 0.2%	3,757,600 $10.2 Million
Q4 2018 Feb 12, 2019	SELL	$3.94 - $9.7 $93,772 - $230,859	-23,800 Reduced 0.63%	3,765,000 $18.1 Million
Q3 2018 Nov 13, 2018	SELL	$8.6 - $11.26 $296,700 - $388,470	-34,500 Reduced 0.9%	3,788,800 $35.9 Million
Q3 2017 Nov 13, 2017	BUY	$5.4 - $8.47 $20.6 Million - $32.4 Million	3,823,300	3,823,300 $29.2 Million

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Account